We are pleased to announce the first awards in our Partnerships and impact funding competition which is designed to catalyse the transfer of 3Rs models, tools and technologies between labs, helping to build confidence and capacity in their use and accelerate their adoption into routine scientific practice.
The seven awards support the sharing of 3Rs approaches between labs working in the areas of infectious disease, oncology and cardiovascular research – two of the awards focus on refining animal use in metabolic and cancer studies, one on reducing animal use in parasitic disease research and four on replacing animal use. The latter includes partnerships for the sharing of organoids, organ-on-chip and human explant models, between teams working in immunology, bone cancer, thrombosis, stroke and aortic aneurysm research.
The Partnerships and impact scheme is a key component of the NC3Rs strategy – providing funding to build new collaborations between 3Rs model developers and end-users, share knowledge and know-how, and enable 3Rs approaches to be tested alongside established in vivo models. Importantly, the awards support the characterisation and qualification* work, including comparative, feasibility and reproducibility studies, that are required to expedite the uptake of 3Rs approaches and promote awareness and buy-in across disciplines and research fields.
Credit: NC3Rs – https://nc3rs.org.uk/